Taken together, these results suggest that TTR, by binding Aβ peptide, participates in its transport from the brain to the periphery and in its subsequent uptake and degradation at the liver, thus preventing Aβ brain deposition and avoiding AD progression. The gene discussed is TTR; the disease is Alzheimer disease.